These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3742507)

  • 21. Effects of tamoxifen on estrogen and progesterone receptors in human breast cancer.
    Waseda N; Kato Y; Imura H; Kurata M
    Cancer Res; 1981 May; 41(5):1984-8. PubMed ID: 7214366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor: National Cancer Institute of Canada Clinical Trials Group MA.17.
    Goss PE; Ingle JN; Martino S; Robert NJ; Muss HB; Piccart MJ; Castiglione M; Tu D; Shepherd LE; Pritchard KI; Livingston RB; Davidson NE; Norton L; Perez EA; Abrams JS; Cameron DA; Palmer MJ; Pater JL;
    J Clin Oncol; 2007 May; 25(15):2006-11. PubMed ID: 17452676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and experimental aspects of hormone receptors in breast carcinoma patients.
    Spona J; Kolb R; Reiner G; Jakesz R; Moser K; Rainer H
    Cancer Detect Prev; 1983; 6(1-2):227-34. PubMed ID: 6883382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.
    Pujol P; Daures JP; Thezenas S; Guilleux F; Rouanet P; Grenier J
    Cancer; 1998 Aug; 83(4):698-705. PubMed ID: 9708933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen and progesterone receptors in uterine sarcomas.
    Sutton GP; Stehman FB; Michael H; Young PC; Ehrlich CE
    Obstet Gynecol; 1986 Nov; 68(5):709-14. PubMed ID: 3763088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of tamoxifen on the content of cytoplasmic steroid hormone receptors of the tumor in patients with cancer of the corpus uteri].
    Tsyrlina EV; Sofroniĭ DF; Dil'man VM; Bokhman IaV; Vishnevskiĭ AS
    Vopr Onkol; 1989; 35(6):675-80. PubMed ID: 2750079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Response of estrogen and progesterone receptors to treatment with large doses of progestogen (depo-provera) in endometrial cancer].
    Thurzó L
    Zentralbl Gynakol; 1990; 112(17):1111-5. PubMed ID: 2148245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Steroid hormone receptors and cellular proliferative activity following the short-term use of tamoxifen and chlorotrianisene in breast cancer].
    Vyshinskaia GV; Murav'eva NI; Shelsputina ZF; Kuz'mina ZV; Nikolaeva TG
    Eksp Onkol; 1985; 7(5):66-8. PubMed ID: 4065023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen receptor content in nuclear pellet from adenocarcinoma corporis uteri biopsies.
    Horvath G; Tropé C; Fernö M; Alm P
    Neoplasma; 1989; 36(5):611-4. PubMed ID: 2812155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenocarcinoma of the cervix. Expression and clinical significance of estrogen and progesterone receptors.
    Fujiwara H; Tortolero-Luna G; Mitchell MF; Koulos JP; Wright TC
    Cancer; 1997 Feb; 79(3):505-12. PubMed ID: 9028361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
    Menendez JA; Oza BP; Atlas E; Verma VA; Mehmi I; Lupu R
    Oncogene; 2004 Jun; 23(28):4945-58. PubMed ID: 15094777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trial.
    Dowsett M; Allred C; Knox J; Quinn E; Salter J; Wale C; Cuzick J; Houghton J; Williams N; Mallon E; Bishop H; Ellis I; Larsimont D; Sasano H; Carder P; Cussac AL; Knox F; Speirs V; Forbes J; Buzdar A
    J Clin Oncol; 2008 Mar; 26(7):1059-65. PubMed ID: 18227529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Infiltrating duct breast carcinoma: the role of estradiol and progesterone receptors].
    Salazar Esquivel EL; Morales Nájar R; Calzada Sánchez L
    Ginecol Obstet Mex; 1994 Mar; 62():85-90. PubMed ID: 8168725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hormonal therapy of endometrial cancer].
    Kato J
    Gan No Rinsho; 1985 Jul; 31(9 Suppl):1182-8. PubMed ID: 4057575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of steroid hormone receptors in breast cancer patients on tamoxifen.
    Encarnación CA; Ciocca DR; McGuire WL; Clark GM; Fuqua SA; Osborne CK
    Breast Cancer Res Treat; 1993; 26(3):237-46. PubMed ID: 8251648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M; Kodama T
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Metastatic breast cancers: comparison of the prognostic significance and the sensitivity to chemotherapy according to the presence of estradiol and progesterone receptors].
    Pouillart P; Madgelenat H; Jouve M; Palangie T; Garcia-Giralt E; Bretaudeau B; Polijcak M; Asselain B
    Bull Cancer; 1982; 69(5):461-7. PubMed ID: 7165808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progression of human endometrial adenocarcinoma heterotransplanted into nude mice from hormone-sensitive to hormone resistant growth.
    Horvath G; Fernö M; Baldetorp B; Cameron R; Ranstam J
    In Vivo; 1991; 5(2):185-90. PubMed ID: 1768790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormonal and receptor status in postmenopausal women with endometrial carcinoma before and after treatment with tamoxifen.
    Luciani L; Oriana S; Spatti G; Secreto G; Recchione C; Grignoglio E; Andreola S; Coradini D; Ronchi E; Di Fronzo G
    Tumori; 1984 Apr; 70(2):189-92. PubMed ID: 6428017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.